Status:
RECRUITING
Effects of Fecal Microbiota Transplantation
Lead Sponsor:
University Hospital, Rouen
Conditions:
Eating Disorders Symptoms
Eligibility:
All Genders
18-50 years
Brief Summary
The intestinal microbiota plays an essential role in digestion and, through the gut-brain axis, in the regulation of weight gain and eating behavior. The balaEating disorders (EDs) are serious patholo...
Detailed Description
The hypothesis of this study is that patients suffering from eating disorders exhibit intestinal dysbiosis that impacts intestinal physiology and eating behavior. This project aims to demonstrate the ...
Eligibility Criteria
Inclusion
- Patients with ED
- Women.
- Aged 18 to 50.
- First consultation in the Nutrition Department of Rouen University Hospital for ED.
- Positive SCOFF with diagnosis of anorexia nervosa, bulimia nervosa, or binge eating disorder.
- Affiliation with a social security plan.
- Patient who has read and understood the information letter and does not object to participating in the study.
- Healthy Volunteers
- Women.
- Aged 18 to 50.
- Body mass index between 18.5 and 24.9 kg/m².
- SCOFF test: no positive response.
- No history of ED or active ED (DSM V criteria negative).
- Affiliation with a social security plan.
- Individual who has read and understood the information letter and does not object to participating in the study.
Exclusion
- Patients with ED
- Men.
- Aged under 18 and over 50.
- Negative SCOFF.
- Patients who have received antibiotic treatment in the last 3 months.
- Patients with a history of IBD or surgical procedures on the digestive tract.
- Patient refuses to participate in the study.
- Persons deprived of liberty by judicial or administrative order.
- Pregnant or breastfeeding women.
- Protected persons (guardianship or curatorship).
- Healthy volunteers
- Men.
- Aged under 18 and over 50.
- SCOFF test with at least one positive response.
- History or active ED (DSM V criteria).
- Persons who have received antibiotic treatment in the last 3 months.
- Person with a history of IBD or surgical procedures on the digestive tract.
- Body mass index less than 18.5 or greater than 24.9 kg/m2.
- Pregnant or breastfeeding women.
- Protected persons (guardianship or curatorship).
Key Trial Info
Start Date :
March 16 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 16 2027
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT07196189
Start Date
March 16 2022
End Date
April 16 2027
Last Update
September 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Rouen Hospital
Rouen, France, 76031